Scroll to explore

Collaboration : a key component of Domain’s DNA

We collaborate with pharmaceutical and biotech companies to advance GPCR drug discovery assets, not only in immuno-oncology, but also in the fields of CNS and rare diseases, in order to bring innovative solutions toward the clinic. Learn more about our latest collaborations here.

Collaboration Programs

Multi-target collaboration for CNS

Discover more

Multi-target collaboration for rare diseases

Discover more

CXCR4 biased agonist

Discover more